chr3-98007864-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001105580.3(GABRR3):c.654C>A(p.His218Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000811 in 1,602,310 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 8/11 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001105580.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRR3 | NM_001105580.3 | c.654C>A | p.His218Gln | missense_variant | 7/10 | ENST00000472788.6 | NP_001099050.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRR3 | ENST00000472788.6 | c.654C>A | p.His218Gln | missense_variant | 7/10 | 5 | NM_001105580.3 | ENSP00000420790.1 | ||
GABRR3 | ENST00000470589.1 | n.501+4480C>A | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000308 AC: 7AN: 227180Hom.: 0 AF XY: 0.0000327 AC XY: 4AN XY: 122302
GnomAD4 exome AF: 0.0000828 AC: 120AN: 1450138Hom.: 0 Cov.: 31 AF XY: 0.0000667 AC XY: 48AN XY: 719932
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2024 | The c.654C>A (p.H218Q) alteration is located in exon 7 (coding exon 6) of the GABRR3 gene. This alteration results from a C to A substitution at nucleotide position 654, causing the histidine (H) at amino acid position 218 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at